120 related articles for article (PubMed ID: 29044424)
1. New hope for symptom management during natural and iatrogenic menopause transitions.
Woodruff TK; Khosla S
Biol Reprod; 2017 Aug; 97(2):177-178. PubMed ID: 29044424
[TBL] [Abstract][Full Text] [Related]
2. [Number of teeth and hormonal profile of postmenopausal women with osteoporosis, osteopenia and normal bone mineral density--a preliminary study].
Stagraczyński M; Kulczyk T; Leszczyński P; Męczekalski B
Pol Merkur Lekarski; 2015 Oct; 39(232):214-8. PubMed ID: 26608487
[TBL] [Abstract][Full Text] [Related]
3. FSH-metabolic circuitry and menopause.
Taneja C; Gera S; Kim SM; Iqbal J; Yuen T; Zaidi M
J Mol Endocrinol; 2019 Oct; 63(3):R73-R80. PubMed ID: 31454787
[TBL] [Abstract][Full Text] [Related]
4. Gaps, limitations and new insights on endogenous estrogen and follicle stimulating hormone as related to risk of cardiovascular disease in women traversing the menopause: A narrative review.
El Khoudary SR
Maturitas; 2017 Oct; 104():44-53. PubMed ID: 28923176
[TBL] [Abstract][Full Text] [Related]
5. Commentary-FSH and bone 2010: evolving evidence.
Iqbal J; Sun L; Zaidi M
Eur J Endocrinol; 2010 Jul; 163(1):173-6. PubMed ID: 20448000
[TBL] [Abstract][Full Text] [Related]
6. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
7. Extragonadal Effects of Follicle-Stimulating Hormone on Osteoporosis and Cardiovascular Disease in Women during Menopausal Transition.
Zhu D; Li X; Macrae VE; Simoncini T; Fu X
Trends Endocrinol Metab; 2018 Aug; 29(8):571-580. PubMed ID: 29983231
[TBL] [Abstract][Full Text] [Related]
8. Hormones and bone loss across the menopause transition.
Karlamangla AS; Shieh A; Greendale GA
Vitam Horm; 2021; 115():401-417. PubMed ID: 33706956
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the hematochemical parameters and bone mineral density of women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and surgical menopause treated with estrogen replacement. Part II].
Savoca S; D'Agosta S; Lombardo G
Minerva Ginecol; 2007 Jun; 59(3):215-22. PubMed ID: 17576400
[TBL] [Abstract][Full Text] [Related]
10. The impact of serum FSH and estradiol on postmenopausal osteoporosis related to time since menopause.
Yoldemir T; Erenus M; Durmusoglu F
Gynecol Endocrinol; 2012 Nov; 28(11):884-8. PubMed ID: 22731753
[TBL] [Abstract][Full Text] [Related]
11. The Pathophysiology and Treatment of Osteoporosis.
Drake MT; Clarke BL; Lewiecki EM
Clin Ther; 2015 Aug; 37(8):1837-50. PubMed ID: 26163201
[TBL] [Abstract][Full Text] [Related]
12. The long-term effect of menopause on postmenopausal bone loss in Japanese women: results from a prospective study.
Okano H; Mizunuma H; Soda M; Kagami I; Miyamoto S; Ohsawa M; Ibuki Y; Shiraki M; Suzuki T; Shibata H
J Bone Miner Res; 1998 Feb; 13(2):303-9. PubMed ID: 9495525
[TBL] [Abstract][Full Text] [Related]
13. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause.
Chakravarti S; Collins WP; Thom MH; Studd JW
Br Med J; 1979 Apr; 1(6169):983-5. PubMed ID: 219937
[TBL] [Abstract][Full Text] [Related]
14. FSH, Bone Mass, Body Fat, and Biological Aging.
Zaidi M; Lizneva D; Kim SM; Sun L; Iqbal J; New MI; Rosen CJ; Yuen T
Endocrinology; 2018 Oct; 159(10):3503-3514. PubMed ID: 30085049
[TBL] [Abstract][Full Text] [Related]
15. [Effect of the steroid sex hormones on the LH and FSH responses to LHRH in the normal subject].
Lemarchand-Béraud T; Reymond M; Rappoport G; Magrini G; Gomez J
Pathol Biol (Paris); 1975 Dec; 23(10):917-22. PubMed ID: 772543
[TBL] [Abstract][Full Text] [Related]
16. Paradigm shift in the pathophysiology of postmenopausal and thyrotoxic osteoporosis.
Zaidi M; Iqbal J; Blair HC; Zallone A; Davies T; Sun L
Mt Sinai J Med; 2009 Oct; 76(5):474-83. PubMed ID: 19787657
[TBL] [Abstract][Full Text] [Related]
17. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
18. Bone turnover alterations across the menopausal transition in south-eastern Chinese women [corrected].
Ma L; Song Y; Li C; Wang E; Zheng D; Qu F; Zhou J
Climacteric; 2016 Aug; 19(4):400-5. PubMed ID: 27147201
[TBL] [Abstract][Full Text] [Related]
19. Bone turnover markers and bone density across the menopausal transition.
Ebeling PR; Atley LM; Guthrie JR; Burger HG; Dennerstein L; Hopper JL; Wark JD
J Clin Endocrinol Metab; 1996 Sep; 81(9):3366-71. PubMed ID: 8784098
[TBL] [Abstract][Full Text] [Related]
20. Follicle-Stimulating Hormone Increases the Risk of Postmenopausal Osteoporosis by Stimulating Osteoclast Differentiation.
Wang J; Zhang W; Yu C; Zhang X; Zhang H; Guan Q; Zhao J; Xu J
PLoS One; 2015; 10(8):e0134986. PubMed ID: 26241313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
